Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism ERβ agonists(Estrogen receptor beta agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hot Flashes | Phase 2 | - | 17 Dec 2009 | |
Vascular Diseases | Phase 2 | - | - | |
Vasomotor symptom | Phase 2 | US | - |
Phase 2 | 99 | Placebo to 17-β estradiol+MK-6913 (MK-6913 75 mg) | kpwhsbluyy(icbdltytxw) = vylxjjxkwz nsfijbyncv (kfpgfcyhjs, hdonwuzacf - lqyibrpmqx) View more | - | 04 May 2016 | ||
Placebo to MK-6913+17-β estradiol (17-β Estradiol 1 mg) | kpwhsbluyy(icbdltytxw) = lxthhxerss nsfijbyncv (kfpgfcyhjs, huqbndzcnj - mmsmteqfnz) View more |